Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer
NCT03221881
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Pegylated Liposomal Doxorubicin and docetaxel
Sponsor
Hebei Medical University Fourth Hospital